Unknown

Dataset Information

0

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.


ABSTRACT:

Introduction

Antibody to hepatitis B core antigen (HBcAb) is known to be related with the prognosis for patients with hepatocellular carcinoma (HCC). This study aims to evaluate the prognostic capacity of HbcAb and other donor/recipient hepatitis B seroepidemiological indexes in transplantation for HCC.

Methods

Based on the national liver transplant registry, we analyzed the prognostic capacity of HBcAb in liver transplantation for patients with HCC of different etiological backgrounds. The hepatitis B virus (HBV)-related HCC cohort was further studied regarding donor/recipient hepatitis B seroepidemiology, and then divided into a training cohort (n = 1,222) and a validation cohort (n = 611) to develop a pretransplant recurrence-risk predicting nomogram.

Results

Positive HbcAb in recipients was related to an increased risk of post-transplant tumor recurrence in HBV-related (n = 1,833, P = 0.007), HCV-related (n = 79, P = 0.037), and non-B non-C HCC (n = 313, P = 0.017). In HBV-related HCC (n = 1,833), donor hepatitis B surface antigen (HbsAg) was also associated with post-transplant tumor recurrence (P = 0.020). Multivariate analysis showed that the matching status of recipient HbcAb and donor HbsAg (MSHB) was an independent prognostic factor (P = 0.017). HbcAb-positive recipients matched with HbsAg-positive donors displayed the worst post-transplant outcomes (P < 0.001). In the training cohort (n = 1,222), a risk-predicting nomogram was established based on ?-fetoprotein, Milan criteria, and MSHB. The model showed excellent prognostic capacity and safely expanded Milan criteria in both training and validation cohorts (P < 0.001).

Discussion

Positive HbcAb in recipients increases the risk of post-transplant tumor recurrence in HCC with different etiological backgrounds. The nomogram based on MSHB is effective in predicting tumor recurrence after transplantation for HBV-related HCC.

SUBMITTER: Lu D 

PROVIDER: S-EPMC7263649 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.

Lu Di D   Yang Fan F   Zhuo Jianyong J   Yang Modan M   Lin Zuyuan Z   Jin Pingbo P   Cai Xuechun X   Cen Beini B   Wang Jianguo J   Wei Xuyong X   Zheng Shusen S   Xu Xiao X  

Clinical and translational gastroenterology 20200501 5


<h4>Introduction</h4>Antibody to hepatitis B core antigen (HBcAb) is known to be related with the prognosis for patients with hepatocellular carcinoma (HCC). This study aims to evaluate the prognostic capacity of HbcAb and other donor/recipient hepatitis B seroepidemiological indexes in transplantation for HCC.<h4>Methods</h4>Based on the national liver transplant registry, we analyzed the prognostic capacity of HBcAb in liver transplantation for patients with HCC of different etiological backgr  ...[more]

Similar Datasets

| S-EPMC3847943 | biostudies-literature
| S-EPMC6324912 | biostudies-literature
| S-EPMC6800587 | biostudies-literature
| S-EPMC8236826 | biostudies-literature
| S-EPMC6309394 | biostudies-other
| S-EPMC8177410 | biostudies-literature
| S-EPMC8121953 | biostudies-literature
| S-EPMC3285232 | biostudies-literature
| S-EPMC8640566 | biostudies-literature
| S-EPMC8326938 | biostudies-literature